Target intelligence / Profile preview

Listeria monocytogenes cell-surface receptors (Inl)

Target
Inl
Molecular classification
Bacterial surface protein, Adhesin, Invasin, Leucine-rich repeat (LRR) protein
01

Overview

Listeria monocytogenes cell-surface receptors, primarily the internalin family (InlA, InlB), are critical bacterial proteins that mediate the attachment and internalization of the pathogen into host cells (1.2.1, 1.2.5). Internalin A (InlA) specifically interacts with host E-cadherin, facilitating entry into epithelial cells, while Internalin B (InlB) binds to the Met receptor (hepatocyte growth factor receptor) to promote entry into a wider range of cell types, including hepatocytes and endothelial cells (1.2.3, 1.2.4). These surface proteins are essential for the bacterium to cross physiological barriers, such as the intestinal, blood-brain, and placental barriers, leading to severe infections like listeriosis (1.2.2, 1.3.5). While traditional treatment for listeriosis involves antibiotics like ampicillin and gentamicin, these surface receptors are significant targets for the development of novel therapeutics, including monoclonal antibodies and antisense oligonucleotides designed to block bacterial entry (1.1.1, 1.1.3). Understanding the structural basis of these interactions is vital for designing inhibitors that can prevent the systemic spread of the infection (1.3.3, 1.3.4).

Other names
Internalin proteinsInternalin A (InlA)Internalin B (InlB)Listeria surface invasinsListeria adhesinsListeria monocytogenes surface proteins
02

Mechanism of action

Inhibition of bacterial attachment and entry into host cells by blocking the interaction between bacterial internalins and host cell receptors such as E-cadherin and the Met receptor (1.1.2, 1.2.3).

03

Biological functions

Cell adhesionHost cell invasionPathogenesisCrossing physiological barriersEndocytosis induction
04

Disease associations

ListeriosisInfectionMeningitisSepsisGastroenteritisNeonatal infection
05

Safety considerations

Potential for off-target effects if host receptors (e.g., Met, E-cadherin) are inadvertently inhibitedBacterial resistance through mutations in surface protein genesChallenges in drug delivery to intracellular bacterial populations
06

Interacting drugs

Luteolin

4 more in the full profile.

07

Biomarkers

InlA protein expressionInlB protein expressioninlA gene detectioninlB gene detection

Beyond the preview

Go deeper on Listeria monocytogenes cell-surface receptors (Inl).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Listeria monocytogenes cell-surface receptors (Inl).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call